10 Stocks to Sell NOW! 3 Stocks to DOUBLE This Year The 10 Best Stocks to Own in 2023 7 Stocks to Buy and Hold Forever 60.4% of Aligos Therapeutics shares are held by institutional investors.

March 14, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”, “Company”), a clinical stage biopharmaceutical company focused on improving patient outcomes through ...

After hours: March 20 at 7:50:46 PM EDT Loading Chart for ALGS ...

Welcome to the September edition of Changing Faces. September ushered in a wave of significant appointments across the pharmaceutical and biotechnology industries, with companies from big pharma ...

Summit Therapeutics Inc., a biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies in the ...

Following recent breakthroughs, led by Allogene Therapeutics and Sana Biotechnology, it’s evident that 2025 is going to be a year marked by allogeneic innovation and clinical success.

If you're interested in exploring more stocks under $20 get an edge over other traders with Benzinga Pro while we're currently offering a 14-day trial. Stocks under $20 offer investors and ...